BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27987595)

  • 1. Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.
    Halvorsen TO; Herje M; Levin N; Bremnes RM; Brustugun OT; Fløtten Ø; Kaasa S; Sundstrøm S; Grønberg BH
    Lung Cancer; 2016 Dec; 102():9-14. PubMed ID: 27987595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
    Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
    Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
    Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
    Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
    Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
    Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
    J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal lung tumor volume changes in small-cell lung cancer patients undergoing chemoradiotherapy.
    Yee D; Rathee S; Robinson D; Murray B
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):142-7. PubMed ID: 20646851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
    Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
    Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
    Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K
    Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
    Valan CD; Slagsvold JE; Halvorsen TO; Herje M; Bremnes RM; Brunsvig PF; Brustugun OT; Fløtten Ø; Levin N; Sundstrøm SH; Grønberg BH
    Anticancer Res; 2018 Feb; 38(2):871-876. PubMed ID: 29374714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
    Sun JM; Ahn YC; Choi EK; Ahn MJ; Ahn JS; Lee SH; Lee DH; Pyo H; Song SY; Jung SH; Jo JS; Jo J; Sohn HJ; Suh C; Lee JS; Kim SW; Park K
    Ann Oncol; 2013 Aug; 24(8):2088-92. PubMed ID: 23592701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
    Bayman E; Etiz D; Akcay M; Ak G
    Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
    Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
    Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
    Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
    van Loon J; Offermann C; Ollers M; van Elmpt W; Vegt E; Rahmy A; Dingemans AM; Lambin P; De Ruysscher D
    Radiother Oncol; 2011 May; 99(2):172-5. PubMed ID: 21571382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
    Hu X; Bao Y; Xu YJ; Zhu HN; Liu JS; Zhang L; Guo Y; Jin Y; Wang J; Ma HL; Xu XL; Song ZB; Tang HR; Peng F; Fang M; Kong Y; Chen MY; Dong BQ; Zhu L; Yu C; Yu XM; Hong W; Fan Y; Zhang YP; Chen PC; Zhao Q; Jiang YH; Zhou XM; Chen QX; Sun WY; Mao WM; Chen M
    Cancer; 2020 Feb; 126(4):840-849. PubMed ID: 31714592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
    Misumi Y; Okamoto H; Sasaki J; Masuda N; Ishii M; Shimokawa T; Hosomi Y; Okuma Y; Nagamata M; Ogura T; Kato T; Sata M; Otani S; Takakura A; Minato K; Miura Y; Yokoyama T; Takata S; Naoki K; Watanabe K
    BMC Cancer; 2017 May; 17(1):377. PubMed ID: 28549414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Radiotherapy in the Treatment of Small-Cell Lung Cancer.
    Nosaki K; Seto T
    Curr Treat Options Oncol; 2015 Dec; 16(12):56. PubMed ID: 26467930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
    van Loon J; De Ruysscher D; Wanders R; Boersma L; Simons J; Oellers M; Dingemans AM; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Teule J; Rhami A; Thimister W; Snoep G; Dehing-Oberije C; Lambin P
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):329-36. PubMed ID: 19782478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
    Amin NP; Miften M; Kavanagh B; Raben D; Camidge DR; Thornton D; Rochford N; Gaspar LE
    J Thorac Oncol; 2011 Sep; 6(9):1553-62. PubMed ID: 21642862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.